Edition:
United States

People: Camurus AB (CAMX.ST)

CAMX.ST on Stockholm Stock Exchange

67.00SEK
18 Jan 2019
Change (% chg)

3.60kr (+5.68%)
Prev Close
63.40kr
Open
64.30kr
Day's High
69.30kr
Day's Low
62.70kr
Volume
124,611
Avg. Vol
62,441
52-wk High
143.00kr
52-wk Low
59.70kr

Wallstrom, Per 

Mr. Per Olof Wallstrom has been Independent Chairman of the Board at Camurus AB since 2015. He has been Director of the Company since 2010. He is Chairman of the Remuneration Committee and Member of the Audit Committee and Nomination Committee of the Company. He holds Master of Science in Pharmacy from Uppsala University. He has been in senior management at Merck Sharpe & Dohme, AstraZeneca, Pharmacia and Bristol-Myers Squibb and has served as CEO of Q-Med, Melacure and Karo Bio AB. He is currently Chairman of the Board of MB Erikssons Bygg & Fastighet AB, Arosgruppen Fastigheter Fjardingen AB, Arosgruppen Holding AB, Neo Dynamics AB and Patients Pending Ltd, Board member of Hansa Medical AB and Arosia Communication AB as well as Deputy Board member of Reabyran AB. He was previously Chairman of the Board of Aros Arkitekter AB and Chemilia AB as well as Board member of Mediplast AB and Aggal Invest AB.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --